Curaleaf’s Takeover Bid Pushes ACB Stock To Hit Its Biggest Single-Day Rally In Nearly 11 Months
Curaleaf Holdings (CURLF) proposed a $4.00 per-share cash-and-stock takeover of Aurora Cannabis (ACB) after Aurora’s board declined to negotiate, offering a 45% premium to ACB’s 30-day VWAP of $2.75. ACB shareholders would receive 0.3463 CURLF shares plus $0.75 cash, with a $5 cap. Curaleaf cites $1.5B trailing revenue, ~$350M EBITDA, and $40M annual cost savings.
How this was made
The 30-second read
Why it matters
The disclosure includes offer structure (cash plus stock), a stated premium versus Aurora’s 30-day VWAP, and a $5 per-share cap tied to CURLF’s stock performance, which should drive immediate repricing and deal-probability trading.
Market read
This is a first-report M&A catalyst with explicit economics and a same-day surge in the target, creating near-term trading opportunities around deal odds and potential bid changes.
What to watch
The $5 cap if CURLF stock rises materially and the share-adjustment mechanics could affect final economics and arbitrage dynamics for ACB holders.
Background
Curaleaf says it approached Aurora privately on June 23, 2026 and followed up July 7, but Aurora’s board declined to engage.
Ticker impact
Curaleaf disclosed a $4-per-share takeover proposal for Aurora after Aurora’s board declined to engage, setting deal terms and caps.
Near-term volatility likely as traders price odds of engagement and potential bid escalation.
The article provides concrete offer economics, but also states there is no guarantee an offer or transaction will proceed.
Aurora shares surged over 20% after Curaleaf unveiled a $4-per-share cash-and-stock takeover proposal with a 45% premium.
Momentum likely to persist initially, but could fade if negotiations stall or terms are challenged.
The text reports a specific premium, exchange ratio, and immediate market reaction, which are primary drivers for ACB trading.
Market effects
Signals consolidation appetite in global cannabis, potentially tightening deal expectations and valuation floors for other operators.
Could shift sentiment toward North American cannabis names with international medical and European cultivation exposure.
A cross-border combination narrative may influence how investors price international cannabis roll-ups.
Counterpoint
The offer is not formally launched and Aurora’s board already declined engagement, so the market may be overpricing deal probability.
Key entities
- acquirerCuraleaf Holdings
Proposed a $4-per-share cash-and-stock takeover offer for Aurora after Aurora declined negotiations.
- targetAurora Cannabis
Received the proposal; its shares rallied over 20% on the news.
- executiveBoris Jordan
Curaleaf CEO who said the premium and rationale justify taking the proposal directly to shareholders.
